Remission of recalcitrant epidermolysis bullosa acquisita (EBA) with colchicine monotherapy.
A 42-year-old woman with widespread recalcitrant epidermolysis bullosa acquisita (EBA) responded well to colchicine monotherapy after attempts to control her disease with other modalities failed. These included dapsone, tetracycline, prednisolone, and combination of cyclophosphamide/azathioprine with dexamethasone 'pulse therapy'. The useful role of colchicine in controlling some difficult cases of EBA, a therapeutically problematic condition, is stressed.
Arora
Komal Pahuja
KP
Department of Dermatology & STD, UCMS & GTB Hospital, Dilshad Garden, Delhi-110095, India.
Sachdeva
Bharti
B
Singh
Navjeevan
N
Bhattacharya
Sambit Nath
SN
D000328:Adult; D003078:Colchicine / Q000627:therapeutic use*; D003937:Diagnosis, Differential; D016107:Epidermolysis Bullosa Acquisita / Q000175:diagnosis* / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006074:Gout Suppressants / Q000627:therapeutic use*; D006801:Humans; D012008:Recurrence
D006074:Gout Suppressants; D003078:Colchicine